Search by Drug Name or NDC
NDC 00472-0379-45 Clotrimazole and Betamethasone Dipropionate .5; 10 mg/g; mg/g Details
Clotrimazole and Betamethasone Dipropionate .5; 10 mg/g; mg/g
Clotrimazole and Betamethasone Dipropionate is a TOPICAL CREAM in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE.
MedlinePlus Drug Summary
Betamethasone topical is used to treat the itching, redness, dryness, crusting, scaling, inflammation, and discomfort of various skin conditions, including psoriasis (a skin disease in which red, scaly patches form on some areas of the body) and eczema (a skin disease that causes the skin to be dry and itchy and to sometimes develop red, scaly rashes). Betamethasone is in a class of medications called corticosteroids. It works by activating natural substances in the skin to reduce swelling, redness, and itching.
Related Packages: 00472-0379-45Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Betamethasone Topical
Vaginal clotrimazole is used to treat vaginal yeast infections in adults and children 12 years of age and older.. Clotrimazole is in a class of antifungal medications called imidazoles. It works by stopping the growth of fungi that cause infection.
Related Packages: 00472-0379-45Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Clotrimazole Vaginal
Product Information
| NDC | 00472-0379 |
|---|---|
| Product ID | 0472-0379_2ec9b37c-e1fe-46d3-addd-4eba66eb14bd |
| Associated GPIs | 90159902053710 |
| GCN Sequence Number | 036534 |
| GCN Sequence Number Description | clotrimazole/betamethasone dip CREAM (G) 1 %-0.05 % TOPICAL |
| HIC3 | Q5M |
| HIC3 Description | TOPICAL ANTIFUNGAL/ANTI-INFLAMMATORY,STEROID AGENT |
| GCN | 06919 |
| HICL Sequence Number | 003197 |
| HICL Sequence Number Description | CLOTRIMAZOLE/BETAMETHASONE DIPROPIONATE |
| Brand/Generic | Generic |
| Proprietary Name | Clotrimazole and Betamethasone Dipropionate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Clotrimazole and Betamethasone Dipropionate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CREAM |
| Route | TOPICAL |
| Active Ingredient Strength | .5; 10 |
| Active Ingredient Units | mg/g; mg/g |
| Substance Name | BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE |
| Labeler Name | Actavis Pharma, Inc. |
| Pharmaceutical Class | Azole Antifungal [EPC], Azoles [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA076002 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00472-0379-45 (00472037945)
| NDC Package Code | 0472-0379-45 |
|---|---|
| Billing NDC | 00472037945 |
| Package | 1 TUBE in 1 CARTON (0472-0379-45) / 45 g in 1 TUBE |
| Marketing Start Date | 2003-12-16 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.17174 |
| Pricing Unit | GM |
| Effective Date | 2024-02-21 |
| NDC Description | CLOTRIMAZOLE-BETAMETHASONE CRM |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1, 5 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |